Banka Bioloo Intrinsic Value
Banka Bioloo (BANKA) median intrinsic value is ₹30.47 from 3 valuation models (range ₹29–₹38), vs current price ₹76.18 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Also explore BANKA stock price history to track price trends across different timeframes.
BANKA Valuation Methods Summary — DCF, Graham Number & P/E
Banka Bioloo intrinsic value across 3 models vs current price ₹76.18 — upside/downside and value range per method. For current market price and key ratios, visit BANKA stock price BSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹29.09 | ₹26.18 - ₹32.00 | -61.8% | Book Value/Share: ₹29.09, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹37.82 | ₹34.04 - ₹41.60 | -50.4% | Revenue/Share: ₹47.27, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹30.47 | ₹24.38 - ₹36.56 | -60.0% | CF Growth: 5.0%, Discount: 15% |
BANKA Intrinsic Value vs Market Price — All Valuation Models
Banka Bioloo fair value range ₹29–₹38 vs current market price ₹76.18 across 3 valuation models. Browse BANKA financial statements for revenue, profit, balance sheet and cash flow data.
BANKA Intrinsic Value Analysis — Undervalued or Overvalued?
Banka Bioloo median intrinsic value ₹30.47, current price ₹76.18 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of BANKA?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Banka Bioloo (BANKA) is ₹30.47 (median value). With the current market price of ₹76.18, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹29.09 to ₹37.82, indicating ₹29.09 - ₹37.82.
Is BANKA undervalued or overvalued?
Based on our multi-method analysis, Banka Bioloo (BANKA) appears to be trading above calculated value by approximately 60.0%.
BANKA Financial Health — Key Ratios vs Industry Benchmarks
Banka Bioloo financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.08 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -12.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.63x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BANKA Cash Flow Quality — Operating & Free Cash Flow
Banka Bioloo operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹1 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹3 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹7 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹0 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹6 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |